CPI-444 71 is an immune checkpoint inhibitor used as a pyroptotic agent in non-small-cell lung carcinoma (NSCLC) and MM via caspase-1/GSDMD activation [187]. Here, GSDMD is linked to non-small cell lung carcinoma.